Cancer Therapy News and Research

RSS

Innovative blood test boosts accuracy of lung cancer screening

A blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection.

11 Jun 2024

Unlocking the potential of ubiquitin-proteasome system in cancer treatment

A new editorial paper was published in Oncoscience (Volume 11) on May 6, 2024, entitled, "Restoring our ubiquitination machinery to overcome resistance in cancer therapy."

7 Jun 2024

New biological mechanism uncovered for treating breast cancer metastasis to the brain

A study led by researchers from the University of Arizona Cancer Center at UArizona Health Sciences identified a biological mechanism that could lead to more effective treatments for breast cancer that has metastasized to the brain.

7 Jun 2024

New approach reduces the required drug dosage for cancer treatment

Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and limited efficacy.

6 Jun 2024

Common anti-inflammatory drug could combat deadly gut fungus, study finds

A team of UC Davis Health researchers discovered that a common anti-inflammatory drug, mesalamine, can replace the work of good bacteria in fighting the nasty fungus Candida albicans in the gut.

4 Jun 2024

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.

4 Jun 2024

New method enhances the efficacy of bispecific antibody therapies in treating solid tumors

Professor Seung-Woo Lee and PhD candidate Kun-Joo Lee from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH), in collaboration with NeoImmuneTech Director Donghoon Choi and Professors Dae Hee Kim and Sun Shim Choi from Kangwon National University, have revealed a groundbreaking method to significantly enhance the efficacy of bispecific antibody therapies in treating solid tumors.

31 May 2024

New research center delves into ubiquitin's role in cancer

The German Research Foundation (DFG) has now approved a new Collaborative Research Centre in the search for innovative therapies against cancer: Researchers from the Technical University of Munich (TUM), Goethe University Frankfurt and Julius-Maximilians-Universität Würzburg (JMU) have joined forces for this purpose.

31 May 2024

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Natural killer (NK) cells play a crucial role in the first line of host defense by eliminating bacteria, viruses, and mutated cells that might become cancer cells.

30 May 2024

Novel method creates antibody-peptide inhibitor conjugates with enhanced therapeutic efficacy

Tumor cells often hijack normal physiological processes to support their growth, exploiting proteins that are in charge of essential cell functions.

29 May 2024

Reducing cancer treatment frequency could cut greenhouse gas emissions

Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.

28 May 2024

MUSC researchers unravel the mystery of cancer recurrence

MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy.

28 May 2024

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.

28 May 2024

In-vivo imaging to quantify collagen morphology in preclinical melanoma models during immunotherapy

Collagen, a major component of the extracellular matrix, plays a crucial role in tumor development.

23 May 2024

Biological similarities found between "chemo brain" and brain fog after COVID-19

Brain fog after COVID-19 is biologically similar to cognitive impairment caused by cancer chemotherapy, something doctors often refer to as "chemo brain."

22 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Enhanced tumor treatment using antibody-loaded extracellular vesicles

Researchers at Karolinska Institutet in Sweden have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate.

20 May 2024

Enzyme implicated in telomere repair offers new avenues for cancer therapy

A new study led by University of Pittsburgh and UPMC Hillman Cancer Center researchers shows that an enzyme called PARP1 is involved in repair of telomeres, the lengths of DNA that protect the tips of chromosomes, and that impairing this process can lead to telomere shortening and genomic instability that can cause cancer.

7 May 2024

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.

2 May 2024

Ketone supplement boosts efficacy of prostate cancer immunotherapy

Adding a pre-ketone supplement -; a component of a high-fat, low-carb ketogenic diet -; to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers from the University of Notre Dame found.

26 Apr 2024

Cancer Therapy News and Research

Innovative blood test boosts accuracy of lung cancer screening

Unlocking the potential of ubiquitin-proteasome system in cancer treatment

New biological mechanism uncovered for treating breast cancer metastasis to the brain

New approach reduces the required drug dosage for cancer treatment

Common anti-inflammatory drug could combat deadly gut fungus, study finds

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

New method enhances the efficacy of bispecific antibody therapies in treating solid tumors

New research center delves into ubiquitin's role in cancer

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Novel method creates antibody-peptide inhibitor conjugates with enhanced therapeutic efficacy

Reducing cancer treatment frequency could cut greenhouse gas emissions

MUSC researchers unravel the mystery of cancer recurrence

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

In-vivo imaging to quantify collagen morphology in preclinical melanoma models during immunotherapy

Biological similarities found between "chemo brain" and brain fog after COVID-19

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Enhanced tumor treatment using antibody-loaded extracellular vesicles

Enzyme implicated in telomere repair offers new avenues for cancer therapy

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Ketone supplement boosts efficacy of prostate cancer immunotherapy

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest News